These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4721643)

  • 1. [In-vitro dissolution tests. Influence of the execution conditions].
    Simioni L; Bottoni R
    Boll Chim Farm; 1973 Mar; 112(3):191-200. PubMed ID: 4721643
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the conditions of absorption of determined drugs in various pharmaceutical oral forms].
    Cardini C; Stacchini A
    Boll Chim Farm; 1973 Feb; 112(2):104-9. PubMed ID: 4719965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dosage form and resorption].
    Thoma K
    Internist (Berl); 1977 Dec; 18(12):617-27. PubMed ID: 340409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of the starting materials on bioavailability of drugs].
    Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
    Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
    [No Abstract]   [Full Text] [Related]  

  • 5. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I
    Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salt formation to improve drug solubility.
    Serajuddin AT
    Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of drugs from solid dosage forms. II. In vitro and in vivo dissolutions.
    Arayne MS; Sultana N
    J Pak Med Assoc; 1979 Oct; 29(10):218-26. PubMed ID: 117138
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biopharmaceutical considerations of dissolution testing used as a prognostic tool for oral drug adsorption].
    Antal I
    Acta Pharm Hung; 2001 Oct; 71(3):280-8. PubMed ID: 11961894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug liberation and resorption in dosage forms predominantly for rectal therapy].
    Voigt R
    Pharm Prax; 1968; 4():80-4. PubMed ID: 5731123
    [No Abstract]   [Full Text] [Related]  

  • 12. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of dissolution profile in stability tests].
    Lengyel M; Dredán J; Shafir G; Klebovich I; Antal I
    Acta Pharm Hung; 2007; 77(2):132-41. PubMed ID: 17933273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro biopharmaceutical control of pharmaceutical preparations. 8. Mathematical method for the evaluation of dissolution curves determined in flow-through cells].
    Kissné CE; Keserü P
    Acta Pharm Hung; 1986 Mar; 56(2):65-71. PubMed ID: 3705967
    [No Abstract]   [Full Text] [Related]  

  • 16. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical considerations and discussion of the literature.
    Goldberg AH; Gibaldi M; Kanig JL
    J Pharm Sci; 1965 Aug; 54(8):1145-8. PubMed ID: 5882218
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simulated passive absorption of active principles on artificial lipid membranes].
    Robert H; Guyot-Hermann AM; Lefebvre C
    Lille Med; 1980; 25(6):311-7. PubMed ID: 7401903
    [No Abstract]   [Full Text] [Related]  

  • 18. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drugs and the organism. II. Bioavailability].
    Pflegel P; Pfeifer S
    Pharmazie; 1980; 34(5-6):337-59. PubMed ID: 6893363
    [No Abstract]   [Full Text] [Related]  

  • 20. A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption.
    Dunne A; O'Hara T; Devane J
    Stat Med; 1999 Jul; 18(14):1865-76; discussion 1877. PubMed ID: 10407257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.